Voyager Therapeutics SG&A Expense (Quarterly) Analysis

Voyager Therapeutics Inc (VYGR)

8.43 -0.20 (-2.32%) USD | NASDAQ | May 17, 16:00

8.43 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	8.607M
December 31, 2023	10.24M
September 30, 2023	8.258M
June 30, 2023	8.294M
March 31, 2023	9.028M
December 31, 2022	8.462M
September 30, 2022	7.307M
June 30, 2022	7.552M
March 31, 2022	7.659M
December 31, 2021	8.351M
September 30, 2021	8.714M
June 30, 2021	10.44M
March 31, 2021	9.744M
December 31, 2020	8.27M
September 30, 2020	8.277M
June 30, 2020	8.239M
March 31, 2020	10.21M
December 31, 2019	9.891M
September 30, 2019	8.463M
June 30, 2019	8.322M

Date	Value
March 31, 2019	9.659M
December 31, 2018	8.255M
September 30, 2018	6.609M
June 30, 2018	11.76M
March 31, 2018	7.182M
December 31, 2017	5.366M
September 30, 2017	4.942M
June 30, 2017	4.516M
March 31, 2017	4.914M
December 31, 2016	3.481M
September 30, 2016	3.37M
June 30, 2016	2.854M
March 31, 2016	3.565M
December 31, 2015	3.157M
September 30, 2015	2.475M
June 30, 2015	2.396M
March 31, 2015	1.881M
December 31, 2014	1.536M
September 30, 2014	1.257M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

7.307M

Minimum

Sep 2022

10.44M

Maximum

Jun 2021

8.716M

Average

8.406M

Median

SG&A Expense (Quarterly) Benchmarks